ArticleJPGN reports2025
Chronic atrial and intestinal dysrythmia syndrome: A late-onset intestinal pseudo-obstruction and cardiac dysfunction due to an SGO1 mutation.
Article in JPGN reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Pediatric intestinal pseudo-obstruction (PIPO) is a rare, heterogeneous, and severe gut motility disorder. In 2014, Chetaille et al. described chronic atrial and intestinal dysrhythmia (CAID) syndrome associated with a recessive SGO1 mutation (p.Lys23Glu) linking it to both intestinal pseudo-obstruction and cardiac dysrhythmia. This study aimed to describe the clinical and nutritional features and outcomes of pediatric patients with the homozygous SGO1 (p.Lys23Glu) mutation. Methods: We retrospectively enrolled children under 18 years with PIPO and homozygous (p.Lys23Glu) SGO1 mutation. Results: Eight patients were included (five girls), two were first-degree relatives. All exhibited a typical PIPO clinical presentation, but with a later onset than usually seen in primary PIPO (median age: 6.3 years). Contrast studies revealed massively distended small bowel and colon in all patients. Antroduodenal and/or colonic manometry, performed in six patients, revealed a neuropathic pattern. A full-thickness intestinal biopsy showed variable fibrosis of the smooth muscle internal layer associated with an abnormal presence of Cajal cells within the muscular layers. All patients required parenteral nutrition (PN) at a median age of 11.8 years. Five patients needed an ileostomy. At 18 years, one patient was off PN. Three patients developed sinus dysfunction: one at the time of PIPO diagnosis and two later. All required pacemakers. One patient died in her twenties secondary to cardiac complications. Conclusions: Recessive SGO1 mutation is a form of late onset PIPO associated with sinus dysfunction. Long-term outcome is unclear. Cardiac, intestinal, and neurologic follow-up is recommended as cerebral small vessel disease has been described in adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.